ARTICLE | Clinical News
Thravixa fully human anthrax mAb regulatory update
May 23, 2011 7:00 AM UTC
The European Commission granted Orphan Drug designation for Emergent's Thravixa to treat inhalation anthrax disease. The human anthrax mAb is in Phase I testing for the indication. ...